Literature DB >> 37595

Endorphins, dopamine, and schizophrenia.

J Volavka, L G Davis, Y H Ehrlich.   

Abstract

The theory that alterations of dopaminergic synaptic transmission may play a role in the pathogenesis of schizophrenia is widely accepted. A more recent theory links the endorphin system to the etiology of schizophrenia. We propose that these two theories may be combined into a single model. Recent neurochemical and pharmacological findings have indicated close functional relationships between the endorphin and dopamine systems. Endorphins modulate dopaminergic synaptic transmission by exerting both presynaptic and postsynaptic effects. On the molecular level, this modulation may involve the activity of nucleotide cyclases and protein phosphorylation systems. Thus, the dopaminergic neuronal hyperactivity, currently believed to be related to schizophrenia, may be caused by a primary alteration in the endorphin system. Several hypotheses about the nature of that alteration have been advanced and tested in therapeutic experiments with schizophrenic patients. These experiments have not yet yielded definitive results.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 37595     DOI: 10.1093/schbul/5.2.227

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  9 in total

1.  Effect of naloxone on the state of patients with endogenous psychoses.

Authors:  R R Lideman; G P Panteleeva; F E Vartanyan; B S Belyaev
Journal:  Neurosci Behav Physiol       Date:  1984 Nov-Dec

Review 2.  Sexual behavior of the male schizophrenic: the impact of illness and medications.

Authors:  J N Nestoros; H E Lehmann; T A Ban
Journal:  Arch Sex Behav       Date:  1981-10

3.  Overrated hedonic judgment of odors in patients with schizophrenia.

Authors:  Małgorzata Urban-Kowalczyk; Janusz Śmigielski; Magdalena Kotlicka-Antczak
Journal:  CNS Neurosci Ther       Date:  2018-04-11       Impact factor: 5.243

4.  Pain perception in schizophrenia: influence of neuropeptides, cognitive disorders, and negative symptoms.

Authors:  Małgorzata Urban-Kowalczyk; Justyna Pigońska; Janusz Śmigielski
Journal:  Neuropsychiatr Dis Treat       Date:  2015-08-06       Impact factor: 2.570

5.  Odor perception and hedonics in chronic schizophrenia and in first episode psychosis.

Authors:  Małgorzata Urban-Kowalczyk; Dominik Strzelecki; Janusz Śmigielski; Magdalena Kotlicka-Antczak
Journal:  Neuropsychiatr Dis Treat       Date:  2019-03-05       Impact factor: 2.570

6.  The Relationship Between Course of Illness and β-Endorphin Plasma Levels in Patients with Schizophrenia.

Authors:  Małgorzata Urban-Kowalczyk; Magdalena Kotlicka-Antczak; Dominik Strzelecki; Ewa Rudecka; Janusz Śmigielski
Journal:  Neuropsychiatr Dis Treat       Date:  2019-12-31       Impact factor: 2.570

7.  Comparison of beta-endorphin and CGRP levels before and after treatment for severe schizophrenia.

Authors:  Małgorzata Urban-Kowalczyk; Janusz Śmigielski; Dominik Strzelecki
Journal:  Neuropsychiatr Dis Treat       Date:  2016-04-15       Impact factor: 2.570

8.  Plasma β-Endorphin Concentration and Antipsychotic Treatment Outcome in Schizophrenia: 1-Year Follow-Up.

Authors:  Małgorzata Urban-Kowalczyk; Magdalena Kotlicka-Antczak; Dominik Strzelecki; Ewa Rudecka; Janusz Śmigielski
Journal:  Med Sci Monit       Date:  2020-09-06

9.  The Relationship Between Antipsychotic Treatment and Plasma β-Endorphin Concentration in Patients with Schizophrenia.

Authors:  Małgorzata Urban-Kowalczyk; Magdalena Kotlicka-Antczak; Dominik Strzelecki; Ewa Rudecka; Janusz Śmigielski
Journal:  Neuropsychiatr Dis Treat       Date:  2021-02-16       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.